昭衍新药:股东拟将合计减持比例由4.1%调整为3%

每日经济新闻
Mar 17

每经AI快讯,3月17日,昭衍新药(603127.SH)公告称,股东顾晓磊、顾美芳拟将合计减持比例由不超过占公司总股本的4.1026%调整为3.00%,同时减持方式由集中竞价调整为集中竞价和大宗交易相结合的方式。(文章来源:每日经济新闻)

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10